Sarah Nash
About Sarah E. Nash
Independent Chair of the Board at Bath & Body Works (BBWI); age 71; director since 2019 (tenure ~5.9 years). Previously Executive Chair (Feb 2022–Jan 2023) and Interim CEO (May–Nov 2022) during leadership transition; CEO & owner of Novagard Solutions since 2018; retired Vice Chairman of Global Investment Banking at JPMorgan after nearly 30 years (retired July 2005). BA, Vassar College; recognized for capital markets, strategic transactions, operations, and corporate governance expertise .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Bath & Body Works | Executive Chair; Interim CEO | Executive Chair: Feb 2022–Jan 2023; Interim CEO: May–Nov 2022 | Led transition after CEO resignation; continuity of governance |
| Novagard Solutions | CEO & Owner | 2018–present | Operates industrial silicones and foam solutions manufacturer; operating leadership |
| JPMorgan Chase & Co. | Vice Chairman, Global Investment Banking | ~30 years; retired July 2005 | Capital markets, strategic transactions leadership |
| Knoll, Inc. | Director | 2006–2021 (until acquisition by Herman Miller) | Design/furniture sector governance experience |
External Roles
| Organization | Role | Start | Notes |
|---|---|---|---|
| Blackbaud, Inc. | Director (public company) | 2010 | Current public board service |
| HBD Industries, Inc. | Director | n/a | Private company board |
| New York-Presbyterian Hospital | Trustee | n/a | Non-profit governance |
| Smithsonian Tropical Research Institute (Panama) | Member | n/a | Scientific institution advisory role |
| Montreal Museum of Fine Arts | Chair, International Advisory Board | n/a | Cultural institution leadership |
| Cleveland Museum of Art | Trustee | n/a | Cultural institution governance |
Board Governance
- Board leadership: Independent Chair (Nash); CEO and Chair roles separated; no Lead Independent Director needed due to independent Chair .
- Independence: All directors except the CEO are independent. Board assessed Nash’s interim executive service and one-time 2022 RSU award and affirmed her independence under NYSE standards after that service ended .
- Attendance: Board held six meetings in fiscal 2024; all then-current directors attended at least 75% of board and committee meetings; nearly all attended the 2024 annual meeting .
- Executive sessions: Independent directors meet in executive session at every regular Board meeting; Nash chairs those sessions .
- Committees (100% independent): Nash is not listed on standing committees; she serves as Board Chair.
- Audit Committee: Chair Steven Voskuil; members Francis Hondal, Juan Rajlin, Stephen Steinour, J.K. Symancyk; 8 meetings; all members qualify as “audit committee financial expert” .
- Human Capital & Compensation (HCC): Chair Francis Hondal; members Alessandro Bogliolo, Lucy Brady, Danielle Lee, Stephen Steinour, Steven Voskuil; 7 meetings; oversees compensation philosophy, clawbacks, ownership guidelines .
- Nominating & Governance: Chair Alessandro Bogliolo; members Lucy Brady, Danielle Lee, Juan Rajlin, J.K. Symancyk; 4 meetings; oversees board refreshment and evaluations .
Fixed Compensation
- Director cash retainer schedule (FY2024):
- Board Chair cash retainer: $250,000 .
- Other directors: $100,000; Audit/HCC membership: +$25,000; Nominating & Governance membership: +$20,000; Committee Chairs: Audit/HCC +$25,000; N&G +$20,000 .
- Sarah Nash FY2024 director compensation:
- Cash: $250,000 .
- Committee fees: $0 (not a standing committee member) .
- Total cash: $250,000 .
| Component | FY2024 Amount ($) |
|---|---|
| Board Chair Cash Retainer | 250,000 |
| Committee Membership Fees | 0 |
| Total Cash | 250,000 |
Performance Compensation
- Director equity retainer (RSUs):
- Board Chair annual stock retainer: $250,000; vests one year after grant, generally subject to continued service; RSUs granted under the 2020 Plan .
- Sarah Nash FY2024 stock awards (grant-date fair value): $245,030; one-year vesting .
| Equity Element | FY2024 Grant-Date Fair Value ($) | Vesting Terms |
|---|---|---|
| Annual RSU Retainer (Board Chair) | 245,030 | RSUs vest one year post-grant, continued service required |
No director options or PSUs are disclosed for directors; equity is time-vested RSUs. Performance metrics (operating income margin, relative TSR) apply to executive PSUs, not to directors .
Other Directorships & Interlocks
| Area | Detail |
|---|---|
| Current public boards | Blackbaud, Inc. (since 2010) |
| Former public boards | Knoll, Inc. (2006–2021) |
| HCC Participation & Interlocks | No HCC member is a current/former BBWI officer; no cross-compensation committee interlocks with BBWI executives on other companies’ boards |
Expertise & Qualifications
- Capital markets and corporate finance (JPMorgan vice chair; ~30 years) .
- Strategic transactions and operations (Novagard CEO & owner) .
- Corporate governance leadership (Independent Board Chair; prior Executive Chair/Interim CEO) .
- Board service across public/private and non-profit institutions .
Equity Ownership
| Holder | Shares Beneficially Owned | % of Class | Notes |
|---|---|---|---|
| Sarah E. Nash | 259,714 | <1% | As of April 8, 2025; no pledged shares by board members or NEOs |
- Director stock ownership guidelines: All independent directors must own BBWI common stock equal to 6x annual cash retainer by October 2028; all directors are in compliance or on track .
Insider Trades
| Date | Type | Shares | Notes / Source |
|---|---|---|---|
| 2024-06-18 | Sale | 48,000 | Director sale reported; article cites SEC Form 4 |
| 2025-03-12 | Form 4 (RSUs) | n/a | Filing notes 1-for-1 conversion; final tranche vesting on March 10, 2025 |
Company insider trading policy prohibits hedging and short-selling; pledging requires advance approval; none of the Company’s stock held by NEOs or Board members is pledged .
Governance Assessment
- Board effectiveness: Robust governance framework with independent Chair, 90% independent directors, separated CEO/Chair roles, independent committees, regular executive sessions, and annual self-evaluations; strong shareholder rights (majority voting, proxy access, special meetings at 25%) .
- Independence & conflicts: Board formally determined Nash remains independent post-interim executive service and one-time RSU award; no related person transactions in FY2024; HCC shows no interlocks; use of independent compensation consultants (Wills Towers Watson in 2024; Meridian in 2025) with independence checks .
- Alignment & incentives: Director equity retainer and 6x ownership guideline support alignment; Nash held 259,714 shares as of April 8, 2025; say-on-pay support was high (96.05%) in 2024, indicating investor endorsement of compensation governance .
- Engagement & attendance: Board met six times; all directors met the 75%+ attendance threshold; independent directors meet every regular meeting without management, chaired by Nash .
- Risk indicators & red flags: No related-party transactions disclosed; no pledging; notable open-market sale of 48,000 shares in June 2024 is a signal to monitor for trading cadence but not, by itself, a governance breach given ownership guidelines and independence affirmations .